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SUMMARY
Using the technique of nuclear magnetic resonance (NMR, MR, MRI), the first
images displaying pathology in humans were published in 1980.1 Since then,
there has been a rapid extension in the use of the technique, with an estimated
225 machines in use in the USA at the end of 1985.2 Considerable enthusiasm
has been expressed for this new imaging technique,3 although awareness of its
high cost in the present economic climate has led to reservations being expressed
in other quarters.2 The aim of this article is to give an outline of the present state
of NMR, and indicate some possible future developments.
HISTORY
The phenomenon of NMR was first described simultaneously by Bloch and
Purcell in 1946,4, 5both scientists subsequently receiving the Nobel prize for their
discovery. Following their initial description, NMR signals from small samples
were obtained using small bore, high field magnets. Analysis of such signals
allowed identification of nuclei within the sample and also differentiation of nuclei
in different chemical environments; this technique of NMR spectroscopy is now a
standard method of chemical analysis of small volumes but gives no spatial
information. It has, in fact, been applied in humans although the technique is still
at a very early stage.6 7
Use of the technique for imaging in medicine required some method of spatial
localisation as well as a magnet big enough to hold a patient. Also, whilst in
theory any paramagnetic atomic nucleus may be studied, the relative abundance
ofhydrogen nuclei (protons) compared with all other species means thatthey are
most suited to study using NMR. The first proton NMR image was published in
1973 by Lauterbur;8 and human in vivo images followed in 19779. 10, 11 with the
first pathology demonstrated in 1980.1
TECHNICAL ASPECTS
Physics
Only a brief description will be given here; fuller accounts are available
elsewhere.12, 13,14 The phenomenon of NMR depends on the fact that nuclei
containing an odd number of protons or neutrons behave as tiny magnets, i.e.
they have a magnetic moment. Ofthose present in the body, the most numerous
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are hydrogen (1H), phosphorous (31P), sodium (23Na), carbon (13C), fluorine (19F)
and potassium (39K). The single proton nucleus of hydrogen is by far the
commonest and also has the highest magnetic moment. The protons spin on
their axes and, under certain conditions, when placed in a magnetic field, they
can absorb and emit radiofrequency (RF) energy. This emitted energy can
be detected by an appropriately tuned receiver coil and gives rise to the NMR
signal.
For NMR imaging, the patient is first placed in a strong magnetic field, which is
typically anything from 200 Gauss (0.02 Tesla) to 20,000 Gauss (2.0 Tesla). For
comparison, the strength of the earth's magnetic field is 0.3 - 0.7 Gauss.15 The
long axisof this field isin the long axisof the patient (Fig 1) and isconventionally
labelled the Z direction as shown. Protons in the body align with this field.
Fig 1. The NMR Scanner at the Hammersmith Hospital. Patient is in position for insertion into the
circular cryomagnet (M). Relevant axes are shown (see text).
Within the bore of the magnet are transmitting and receiving RF coils; using a
transmitted RF pulse of specific duration and frequency, the protons can be
rotated 90° into the XY plane, and while spinning in this plane the receiver coil
detects an RF signal. The strength of this signal will depend on the number of
protons present (proton density , o) However, this signal decays rapidly; loss of
coherence (phase) between the spinning protons occurs with a time constant T2
(the spin-spin relaxation time), and the protons also return to the Z direction with
a time constant T1 (the spin-lattice relaxation time). By using different sequences
of 900 and 1800 pulses, the NMR signal can be made dependent to differing
degrees on T1 and T2. A typical pulse sequence might last anything from
500msec to 2000msec and each sequence is repeated many times in order to
build up the NMR image.
Selection of an anatomical slice is achieved by applying a magnetic field gradient
in the Z direction so that only a 'slice' of protons responds to the transmitted
RF pulse. Spatial localisation within the slice is achieved by applying X and Y
gradients, image reconstruction is then carried out by computer using the
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mathematical process of Fourier transformation. Flow effects can be seen on
NMR because of the method of image formation. Blood which flows rapidly
through the slice gives rise to no signal, because data is not retrieved from it, but
slowly flowing blood may give rise to a signal ('paradoxical enhancement').'6
Quantification of flow is possible.'7
Comparison with computed tomography (CT)
NMR sequences sensitive to T, and T2 can produce images with greatersofttissue
contrast than X-ray CT because of the wide range of these values for normal and
pathological tissues. In CT, contrast depends on only one variable, the X-ray
attenuation coefficient. However, because the relative brightness oftissues in the
final NMR image may change drastically with the pulse sequence used,
interpretation requires a knowledge of the physical principles involved if
diagnostic information is not to be missed. Appropriate sequences must be
chosen to highlight any pathology present. Transverse slices of similar thickness
to X-ray CT can be obtained. However, by manipulation of the field gradients,
direct sagittal and coronal images can also be obtained without moving the
patient or the scanner, and oblique scans are also possible.
In CT, a single slice can be obtained in as little as two seconds, allowing breath-
holding, for example in studying the chest and abdomen. In NMR, data
acquisition time for a single slice is usually much longer, and may be anything up
to 15 - 20 minutes for high resolution. This leads to problems with respiratory
motion and patient throughput. However, it is now possible to image a number of
sections simultaneously, reducing effective scanning time to levels comparable to
CT.18 19 A method of respiratory gating without increased scan time is also
available.20
Because of their low proton density, bone and calcium give a low signal on NMR;
thisisanadvantage over CTinsituations where artefacts from bone areaproblem,
for example in the posterior fossa and spine. However, bony abnormalities and
calcified lesions are not well visualised with NMR. No ionising radiation is used in
NMR, a major advantage especially in children and where repeated examinations
are anticipated.
PRACTICAL ASPECTS
Insertion of the patient into the magnet causes claustrophobia in a small
proportion of subjects. Some noise arises from the electronic gradient switching
pulses but this is not usually a problem. Because of the presence of the very
strong magnetic field, loose metallic objects must be excluded from the vicinity of
the magnet, as must the vulnerable magnetic strip of credit cards. There is a
theoretical riskofdisplacementoftheclipsused intreating intracranial aneurysms,
and such patients must be excluded from study. Patients with cardiac pacemakers
may also be at risk as some of these may be affected by the varying fields. No
adverse effects have been demonstrated from NMR,21 but limits on the field
strength and magnitude of the varying fields and RF pulses have been set;22
females in the first trimester of pregnancy are excluded from scanning.
CLINICAL IMAGING
All the images illustrated here were obtained on the NMR imager at the
Hammersmith Hospital. This is a prototype Picker 0.15 Tesla superconducting
scanner operating at a radiofrequency of 6.6 MHz.
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Brain
In the early days of CT, the brain was the first organ to be studied using NMR, on
account of its lack of physiological motion; 1,23,24, 25 consequently knowledge of
the appearances of brain pathology is more advanced than for the rest of the
body.26, 27, 28, 29 Advantages of NMR over CT have been identified; these relate
chieflv to the increased contrast sensitivitv of NMR and lack of bone artefact. The
Fig 2. Transverse scan of brain in multiple
sclerosis. White areasaredemvelinatinq plaques
latter is especially true in the posterior
fossa.30. 31
Multiple sclerosis was one of the first
conditions in which the high contrast
sensitivity of NMR was demonstrated
(Fig 2).32 In a recent study, NMR
demonstrated demyelinated plaques in
85% of patients with definite MS,
compared with 25% on CT.33 Plaques
are typically seen in the periventricular
white matter, centrum semiovale and
posterior fossa, where they are not
seen with CT. They have also been
demonstrated in the cervical spinal
cord.34 A variety of other diseases of
grey and white matter have also been
studied.27' 29, 35, 36, 37
Cerebral tumours are well demonstrated by NMR (Fig 3),38, 39 and the ability to
provide direct sagittal and coronal studies is of value in showing their relation to
other structures for planning of surgery and radiotherapy. Sagittal and coronal
images of posterior fossa and brainstem lesions provide detailed information
unobtainable by CT.40 In the cerebellopontine angle, the absence of bone
signal may eliminate the need for CT contrast studies.42'43 Most tumours have an
increased T1 and T2, but histological diagnosis on the basis of measured values
has not proved possible. Benign tumours such as meningiomas may have a
normal T2 and only a moderate rise in T1, giving rise to characteristic appearances
on NMR.44
Fig 3 (a). Sagittal scan ofbrain. Large metastasis
in cerebellum from bronchial carcinoma (arrow).
Fig 3 (b). Enhancement of tumour margin
following intravenousGd.DTPA. Note enhance-
ment of nasal mucosa (arrow).
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In cerebral infarction, increased T, has been visualised as early as six hours after
onset.45 Small ischaemic lesions can be seen, although their increased detection
has led to difficulties in separating multiple. lesion causinq organic disease
from lesions seen with ageing, which are also
presumably ischaemic in nature.46,47 Intracranial
haemorrhage shows a sequence of changes on
NMR, with a short T, in the subacute stage which
can allow differentiation from other pathology.26
Subdural and extradural haematomas are well
seen due to lack of signal from overlying skull.48
Lack of signal from flowing blood is useful
in demonstrating aneurysms and arteriovenous
malformations.49 A number of patients with
infective conditions have been studied, and in
some cases increased T1 and T2 lesions are
seen.27. 50
In children, a wide variety of pathology has been
studied5l 52,53 and lack of hazard from ionising
radiation is a particular advantage. In addition,
NMR demonstrates the progress of normal
myelination in childhood in a way impossible with
any other technique. Deviations from this pattern
following perinatal insults can be recognised
(Fig 4).52
p
Fig 4. Transverse scan of baby
at 20 months, following perinatal
asphyxia. Small infarct(arrow)and
delayed myelination on the left
side (compare frontal lobes).
Spine
Excellent demonstration of the spinal cord and spine can be obtained using
sagittal views; the cord and subarachnoid space are demonstrated without the
use of contrast medium (Fig 5).54 551Bone marrow in the vertebral bodies gives a
high signal as does the nucleus pulposus of the intervertebral disc.56 NMR can
.: ::...:.:: +_l|l*w~~~~~~~~~~~~~~~~~~~.............. *ffit~~~~~~~~~~~~~~~~~~~~~~..:......... _|*~~~~~~~~~~~~~~~~~~~~~~~~~............,.:..::l: |1¢I~~~~~~~~~~~~~~~~~~~~~~~~~~.............. a:[~~~~~~~~~~~......--t.. |||[~~~~~~~~~~~~~~~~~~..'...K...'.-. *E*E~~~~~~~~~~~~~~~~~~~~......--......_ -I_-_,~~~~~~~~~~~~~~~~~~~~~~~............-,6-.._
Fig 5 (a) Sagittal scan ofnormal cervicalspine.
(upe arrow Char I mafrain
(b) Syrinx in mid-cervical cord (lower arrow).
There is also cerebellar tonsillar herniation
(upper arrow)-Chiari I malformation.
© The Ulster Medical Society, 1986.102 The Ulster Medical Journal
therefore directly demonstrate cord abnorm-
alities such as syringomyelia, in which the
cystic cavity gives a low signal; 57 associated
cerebellar tonsillar herniation can be
assessed at the same time.58 Tumours,59
arteriovenous malformations,60 demyelin-
ating plaques and other abnormalities have
been demonstrated.54,55 Disc herniation can
be recognised with NMR.61 In addition, loss
of the normal signal from the nucleus
pulposus may be an early signal of disc
degeneration.55, 62
Musculoskeletal
Whilst cortical bone and calcium give a low
signal on NMR, the technique has proved
useful indefining theextentofbonetumours,
especially within the marrow (Fig 6).62, 63, 64
Direct coronal and sagittal scans can reveal
the longitudinal extent of the tumour, which
is of particular importance in planning
surgery. NMRhasalso demonstrated marrow
abnormality in leukaemia65 and in the early
stages of avascular necrosis, and may be
useful in other joint disease.62
Fig 6. A coronal scan in a child with
osteosarcoma of thelowerfemur(arrow).
The tumour has broken through the
epiphyseal plate inferiorly.
Abdomen
NMR imaging of the abdomen is hampered by respiratory artefact, although
adequate images can be obtained. Respiratory gating20 and special pulse
sequences66 can reduce this problem. Intheliver, hepatic vesselscan beidentified
without the use ofcontrast medium, and differentiation from bile ducts is possible
(Fig 7a).67, 68 This is valuable in assessing the spread of hepatocellular carcinoma
prior to resection.69 Initial studies indicated that most liver disease increased T1
and that it might be possible to differentiate them on this basis; 70 however, this
has not been confirmed.67,71 One possible exception is cavernous haemangioma,
whose long T2 may allow distinction from other tumours.72 73
In focal liver disease, NMR has a sensitivity comparable with CT (Fig 7b).74 75, 76
In diffuse disease, changes are more variable. Cirrhosis may increase T1, while in
Fig 7 (a). Transverse scan ofabdomen showing
liver metastasiswith areaoflowsignalfrom calci-
fication (arrow). Note low signal from vessels.
Fig 7 (b). Different pulse sequence highlights
tumour (arrow).
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haemochromatosis T, may be reduced: this has been ascribed to the para-
magnetic properties of iron (see Contrast agents, below). However, in Wilson
disease and primary biliary cirrhosis T1 has been increased, presumably due to
the cirrhosis associated with the copper deposition.67 Fatty change has not been
well visualised on NMR, although specialised sequences may show it.76 In portal
hypertension, portal vein flow has been assessed.77
In the kidney, NMR gives good distinction between cortex and medulla and can
visualise Gerota's fascia, the adrenal glands and the renal vessels.78 Loss of
cortico-medullary differentiation has been seen in glomerulonephritis, renal
failure, renal artery stenosis and transplant rejection.78,79 NMR can distinguish
solid masses from cysts,80 and has identified extension of hypernephroma into
the renal vein and vena cava.80 81 The place of NMR in renal, adrenal and
pancreatic disease remains to be established.82
E~~~ ~ ~ ~ ~ ~ ~ ~ ~ ... ......................... 'l _,fy~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.:,
Fig 8. Sagittal scan of normal pelvis.
b = bladder, r= rectum, u = uterine wall. Short
arrow = pubic symphisis, curved arrow = tip of
sacrum.
Pelvis
Lack of respiratory motion makes the
pelvis more suited to NMR scanning,
and direct coronal and sagittal images
are especially valuable in assessing the
cervix and uterus and conditions of the
bladder base (Fig 8).83 84,85 NMR has
shown promise in the distinction of
bladder carcinoma fromotherconditions
and in staging the tumour although the
problems are encountered as on CT in
staging nodal involvement.86 87 In the
male, the prostate, seminal vesicles and
ductus deferens can be demonstrated.85
Prostatic enlargement is well seen on
sagittal studies, although initial enthus-
iasm for the specificity of the findings
in prostatic disease has not been
confirmed.88
In the female, myometrium and endometrium can be distinguished and cyclical
endometrial changes have been seen.83 The cervix contains a band of low signal
intensity and the ovaries are also seen. Benign and malignant gynaecological
conditions have been studied, although more experience is required; NMR may
have a role in staging of malignancy. The pregnant uterus in the second and third
trimester has been studied and also a number of first trimester pregnancies
scheduled for termination. Real-time ultrasound has obvious benefits; it is safe,
inexpensive and not limited by fetal motion. Nevertheless, some possible
advantages of NMR have been identified. The cervix and internal os are well
visualised and their relationship to the placenta evaluated. Bladder distension is
not necessary, and this may be an advantage over ultrasound in diagnosis of
cervical incompetence.89 The fetus is best seen in the last trimester when
movement is least,90,91 and the demonstration of fetal fat by NMR may be of
value in assessing intra-uterine growth retardation.92
Thorax
Mediastinal structures are well seen on NMR, vascular structures giving no signal
due to flowing blood within them.93 This is a major advantage over CT, which
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requires intravenous contrast for vessel delineation. Difficulties arise in CT in
distinguishing large benign lymph nodes from those involved by metastatic
tumour, but NMR encounters the same difficulties94 95 and lack ofvisualisation of
calcification of benign nodes is a disadvantage. NMR may be able to improve
differentiation of central tumour from distally collapsed or consolidated lung.96
Vascular structures are well delineated and a variety of lesions have been
demonstrated, including aortic aneurysm, atheroma and dissection.97 98
Fig 9. Transverse scan ofthorax (ECG gated)
Marked thickening of left ventricle in a patient
with hypertrophic obstructive cardiomyopathy
(arrow)
Gating data acquisition to the R-wave
of the ECG gives good images of the
heart (Fig 9).99 100 Details of cardiac
muscle, chambers, valves and papillary
muscles can be seen.'00 By varying
the data acquisition delay after the R
wave, a series of pictures of the slice
can be built up in different phases of
the cardiac cycle; by 'looping' these
together a cine-type moving image
of cardiac motion can be obtained.
Orientationoftheslicetotheventricular
axes may allow assessment of ventric-
ular volumes and function.'10 However,
this is time-consumina. and multi-
section and volume acquisition techniques are being developed. Echo-planar
imaging can produce true real-time rapid images but resolution is, asyet, poor.102
Following successful animal studies, acute infarcts in man have been successfully
imaged as areas of increased T1.103 104 Subacute and old infarcts appear as
areas of thinned myocardium, and aneurysms and mural thrombus have been
demonstrated.99 Congenital disorders have also been studied.105
NMR images of the breast demonstrate normal ductal structures within the fatty
stroma ofthe breast and can differentiate duct dysplasia, cysts and fibroadenoma
from malignant lesions.106 However, lack of visualisation of calcification, an
important mammographic sign, is a disadvantage. NMR has obvious advantages
as a possible alternative safe screening technique.
Fig 10. Surface coil study of orbits: right
cavernous haemangioma (arrow).
OTHER TECHNIQUES
Surface coils
By placing a copper receiver coil close
to the part being imaged, the NMR
signal quality can be improved allowing
increased resolution. This is of partic-
ular interest in small structures such as
the orbit (Fig 10),'07 and may also be
used in the inner ear, breast, spine and
limbs.108 The principle can, in fact, be
extended to larger organs and, at the
Hammersmith Honnital suirface coils
are used for all examinations including the pelvis, abdomen, chest and brain.109
Surface coils are now offered by most NMR manufacturers.
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Contrast agents
To date, the most widely used contrast agent has been the intravenous agent
gadolinium (Gd3+) chelated to diethylenetriamine penta-acetic acid (DTPA). This
is a paramagnetic ion which exerts local magnetic effects and reduces T, and T2,
thus altering or 'enhancing' the appearance of the tissue in the final image
(Fig 3b). It behaves similarly to iodinated X-ray contrast media in not crossing
the normal blood-brain-barrier and is excreted unchanged by the kidneys.
Gd-DTPA improves differentiation between cerebral tumours and surrounding
oedema 110111 and may also improve detection of metastases.111 Improved visual-
isation of spinal cord tumours has also been seen.112 Enhancement has been
observed in tumours of the liver1l3 and kidney.79
CONCLUSION
NMR has already established itself as the imaging method of choice in several
neurological conditions, while clinical experience is accumulating rapidly for the
rest ofthe body. Study of phosphorous and of other spectra from human subjects
in vivo has already identified some metabolic disorders, for example of muscle
metabolism, although research is still at an early stage and the problem of spatial
localisation with spectroscopy remains to be solved. This would be of great
interest in, for example, monitoring the metabolism of tumours. Imaging using
other nuclei such as sodium has also been achieved.
NMR is more costly than CT, and this together with doubts about its true role has
led to a slower rate ofdiffusion than occurred following the invention of CT.2 It will
most likely prove to have a complementary role to CT rather than replacing it,
and with increasing experience there is no doubtthat NMR will find an established
place as an imaging technique.
Additional costs associated with the illustrations in this review article have been supported by a grant
from the Department of Radiology, Royal Victoria Hospital, Belfast.
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